Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol vs remimazolam vs propofol for perioperative temperature in gynecologic laparoscopy
ChiCTR2600130510Phase 4Not yet recruiting
- Sponsor
- Maternal and Child Health Hospital of Hubei Province
- Start
- Aug 2026
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in anesthesia-induced hypothermia, postoperative nausea and vomiting (PONV), postanesthetic shivering (PAS) and 1 more comparing Ciprofol arm, Propofol arm and Remimazolam arm (3 arms). Primary endpoints: Perioperative body temperature, Incidence of postoperative nausea and vomiting and 1 more. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
ciprofolremimazolampropofol
03
Conditions
anesthesia-induced hypothermiapostoperative nausea and vomiting (PONV)postanesthetic shivering (PAS)postoperative pain
Beyond the preview
Go deeper on ChiCTR2600130510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600130510.